Table 2.
Protein | Gene name | Fold changes in CL users |
|
---|---|---|---|
CL Expt 1 | CL Expt 2 | ||
| |||
Beta-1,3-galactosyl-O-glycosyl- | |||
glycoprotein beta-1,6-N- | GCNT | + 1.9 | + 1.6 |
acetylglucosaminyltransferase 3 | |||
| |||
Corneodesmosin | CDSN | +2.1 | + 1.9 |
| |||
Cystatin-SA | CST2 | + 11.3 | -2.6 |
| |||
Desmocollin-1 | DSC1 | +2.1 | + 1.9 |
| |||
Desmoglein-1 | DSG1 | +2.0 | + 1.7 |
| |||
Desmoplakin | DSP | +2.2 | +1.6 |
| |||
Loricrin | LRN | +2.0 | +2.4 |
| |||
Mesothelin, cleaved form | MSLN | +1.9 | + 1.7 |
| |||
Polymeric immunoglobulin receptor | PIGR | +1.8 | +2.3 |
| |||
Immunoglobulins, 14 | See below * | +1.6 to +2.5 | + 1.8 to +2.9 |
Differential abundance was determined using the uncorrected edgeR p values in these CL analyses. CL Experiment 1 included a wide range of Schirmer strip wetted length, while CL Experiment 2 included samples from a restricted range of Schirmer strip wetted length. Bolded gene names represent proteins that were also elevated in a larger CL comparison with restricted Schirmer strip wetted length using IRS normalization (described below).
14 specific Immunoglobulins were more abundant with CL use: IGHA1, IGHV3–11, IGHV3–49, IGHV3–53, IGHV3–7, IGHV3–74, IGHV4–28, IGHV5–51, IGHV6–1, IGKV1–27, IGKV3–11, IGLV1–44, IGLV3–19, IGLL5